Luna Diabetes
PrivateLast Round
Series A
Aug 18, 2025
Est. Valuation
$45.5M
Total Funding Raised
$23.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Luna Diabetes operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in August 2025.
Luna Diabetes is a medical device company that develops an automated insulin delivery patch pump system designed for nighttime glucose control for insulin pen users.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Clinical Trials, Medical AI
Business Model
B2C
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luna Diabetes Comparables
Compare Luna Diabetes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaSens AG | 78% | |
| ViCentra | 76% | |
| Sequel Med Tech | 76% |
For institutional investors. Book with your work email.
Luna Diabetes Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Luna Diabetes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 2468 Ventures | Series A |
| Serpentine Ventures | Series A |
| Vensana Capital | Series A |
| Winklevoss Capital | Series A |
| Interlock Capital | Series A |
| Credit Suisse Group AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2026
Sleep-Only Automation product has entered clinical studies.
- Aug 1, 2026
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Luna Diabetes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Luna Diabetes's valuation, stock price, and market status.
Is Luna Diabetes a public or private company?
Luna Diabetes is a private company.
What is the current stock price of Luna Diabetes?
Luna Diabetes is a private company, so its shares have no public market price. Caplight tracks Luna Diabetes's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Luna Diabetes worth (valuation)?
Luna Diabetes's valuation is estimated at $45.5M based on funding round data.
Can I buy Luna Diabetes stock?
Luna Diabetes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Luna Diabetes's last funding round?
Luna Diabetes's most recent funding round was Series A on August 18, 2025.
Who are the main investors in Luna Diabetes?
Key investors in Luna Diabetes include Vensana Capital.
Will Luna Diabetes IPO soon?
No public IPO plans have been announced for Luna Diabetes.
How can I track Luna Diabetes secondary market activity?
Caplight tracks bids, offers, and trades in Luna Diabetes's shares on secondary markets.